Search Results - Liberati, M.S.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    HPR200 Evolution in Public Procurement for Medical Devices in Italy

    HPR200 Evolution in Public Procurement for Medical Devices in Italy by Liberati, M.S., Canali, B., Vassallo, C., Mantuano, M., Fiorentino, F.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile -associated polymorphonuclear neutrophil activation

    Phosphatidylcholine and the intestinal mucus layer: in vitro efficacy against Clostridium difficile -associated polymorphonuclear neutrophil activation by Olson, Alicia, M.D, Diebel, Lawrence N., M.D, Liberati, David M., M.S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Dose-Dependent Effects of Ethanol and E. Coli on Gut Permeability and Cytokine Production

    Dose-Dependent Effects of Ethanol and E. Coli on Gut Permeability and Cytokine Production by Amin, Parth B., M.D, Diebel, Lawrence N., M.D, Liberati, David M., M.S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    T-cell cytokines affect mucosal immunoglobulin A transport

    T-cell cytokines affect mucosal immunoglobulin A transport by Amin, Parth B., M.D, Diebel, Lawrence N., M.D, Liberati, David M., M.S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Ethanol Effects Proinflammatory State of Neutrophils in Shock

    Ethanol Effects Proinflammatory State of Neutrophils in Shock by Amin, Parth B., M.D, Diebel, Lawrence N., M.D, Liberati, David M., M.S

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    PF375 IBRUTINIB AND RITUXIMAB AS FRONT‐LINE TREATMENT FOR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). PRELIMINARY RESULTS FROM THE GIMEMA LLC1114 STUDY

    PF375 IBRUTINIB AND RITUXIMAB AS FRONT‐LINE TREATMENT FOR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). PRELIMINARY RESULTS FROM THE GIMEMA LLC1114 STUDY by Mauro, F.R., Molica, S., Paoloni, F., Reda, G., Trentin, L., Marchetti, M., Pietrasanta, D., Coscia, M., Marasca, R., Sportoletti, P., Gaidano, G., Orsucci, L., Stelitano, C., Di Renzo, N., Liberati, A.M., Gottardi, D., Re, F., Ilariucci, F., Zinzani, P., Mannina, D., Gozzetti, A., Molinari, A.L., Gentile, M., Consoli, U., Laurenti, L., Arcaini, L., Ibatici, A., Murru, R., Tani, M., De Propris, M.S., Del Giudice, I., Della Starza, I., Raponi, S., Nanni, M., Fazi, P., Crea, E., Neri, A., Specchia, G., Guarini, A.R., Cuneo, A., Foà, R.

    Published in HemaSphere
    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: